Evidence map›Paper›PMID 33421400›Full record

ArticleAmerican journal of human genetics2021

Genome-wide association study identifies novel susceptibility loci for KIT D816V positive mastocytosis.

Gabriella Galatà, Andrés C García-Montero, Thomas Kristensen, Ahmed A Z Dawoud, Javier I Muñoz-González, Manja Meggendorfer, Paola Guglielmelli, Yvette Hoade, Ivan Alvarez-Twose, Christian Gieger and 17 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Mastocytosis.Nature reviews. Disease primers · 2025
    Review
  4. Review
  5. Mast cell activation syndrome: Current understanding and research needs.The Journal of allergy and clinical immunology · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 15 institutions in 6 countries.

Gabriella GalatàSchool of Medicine, University of Southampton, Southampton SO17 1BJ, UK.
Andrés C García-MonteroInstitute of Biomedical Research of Salamanca, Salamanca 37007, Spain; Servicio de Citometría, Departamento de Medicina, CIBERONC, and Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Salamanca 37007, Spain.
Thomas KristensenDepartment of Pathology, Odense University Hospital, 5000 Odense, Denmark; Mastocytosis Centre Odense University Hospital, 5000 Odense, Denmark.
Ahmed A Z DawoudSchool of Medicine, University of Southampton, Southampton SO17 1BJ, UK.
Javier I Muñoz-GonzálezInstitute of Biomedical Research of Salamanca, Salamanca 37007, Spain; Servicio de Citometría, Departamento de Medicina, CIBERONC, and Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Salamanca 37007, Spain.
Manja MeggendorferMunich Leukemia Laboratory, 81377 Munich, Germany.
Paola GuglielmelliCentro di Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera Universitaria Careggi, Dipartimento di Medicina Sperimentale e Clinica, Università Degli Studi di Firenze, 50134 Firenze, Italy.
Yvette HoadeSchool of Medicine, University of Southampton, Southampton SO17 1BJ, UK.
Ivan Alvarez-TwoseInstituto de Mastocitosis de Castilla La Mancha, Hospital Virgen del Valle, 45071 Toledo, Spain.
Christian GiegerInstitute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany; German Centre for Cardiovascular Research Partner Site Munich Heart Alliance, 80802 Munich, Germany; Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, Germany Research Center for Environmental Health, 85764 Neuherberg, Germany; German Center for Diabetes Research, 85764 Neuherberg, Germany.
Konstantin StrauchInstitute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany; Chair of Genetic Epidemiology, IBE, Faculty of Medicine, LMU Munich, 80539 Munich, Germany; Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Johannes Gutenberg University, 55131 Mainz, Germany.
Luigi FerrucciLongitudinal study section, Translation Gerontology Branch, National Institute on Aging, Baltimore, MD 21224, USA.
Toshiko TanakaLongitudinal study section, Translation Gerontology Branch, National Institute on Aging, Baltimore, MD 21224, USA.
Stefania BandinelliGeriatric Unit, Azienda USL Toscana centro, 50137 Firenze, Italy.
Theresia M SchnurrNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Torsten HaferlachMunich Leukemia Laboratory, 81377 Munich, Germany.
Sigurd Broesby-OlsenMastocytosis Centre Odense University Hospital, 5000 Odense, Denmark; Department of Dermatology and Allergy Centre, Odense University Hospital, 5000 Odense, Denmark; Odense Research Center for Anaphylaxis, Odense University Hospital, 5000 Odense, Denmark.
Hanne VestergaardMastocytosis Centre Odense University Hospital, 5000 Odense, Denmark; Department of Hematology, Odense University Hospital, 5000 Odense, Denmark.
Michael Boe MøllerDepartment of Pathology, Odense University Hospital, 5000 Odense, Denmark; Mastocytosis Centre Odense University Hospital, 5000 Odense, Denmark.
Carsten Bindslev-JensenMastocytosis Centre Odense University Hospital, 5000 Odense, Denmark; Department of Dermatology and Allergy Centre, Odense University Hospital, 5000 Odense, Denmark; Odense Research Center for Anaphylaxis, Odense University Hospital, 5000 Odense, Denmark.
Alessandro M VannucchiCentro di Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera Universitaria Careggi, Dipartimento di Medicina Sperimentale e Clinica, Università Degli Studi di Firenze, 50134 Firenze, Italy.
Alberto OrfaoInstitute of Biomedical Research of Salamanca, Salamanca 37007, Spain; Servicio de Citometría, Departamento de Medicina, CIBERONC, and Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Salamanca 37007, Spain.
Deepti RadiaDepartment of Clinical Haematology, Guy's and St Thomas' NHS Hospitals, London SE1 9RT, UK.
Andreas ReiterUniversity Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Andrew J ChaseSchool of Medicine, University of Southampton, Southampton SO17 1BJ, UK; Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury SP2 8BJ, UK.
Nicholas C P CrossSchool of Medicine, University of Southampton, Southampton SO17 1BJ, UK; Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury SP2 8BJ, UK. Electronic address: ncpc@soton.ac.uk.
William J TapperSchool of Medicine, University of Southampton, Southampton SO17 1BJ, UK.
Odense University Hospital · DKUniversity of Southampton · GBAzienda Ospedaliero-Universitaria Careggi · ITCentro de Investigación del Cáncer · ESMunich Leukemia Laboratory (Germany) · DENational Institute on Aging · USAzienda Usl Toscana Centro · ITCentro de Investigación Biomédica en Red de Cáncer · ESDeutsches Diabetes-Zentrum e.V. · DEHeidelberg University · DEHospital Virgen del Valle · ESJohannes Gutenberg University Mainz · DESt Thomas' Hospital · GBUniversity of Copenhagen · DKWessex Regional Genetics Laboratory · GB

Funding

The Aging Genome Association Study "AGE-GAIN"ZIAAG000965 · NIA · NATIONAL INSTITUTE ON AGING · PI FERRUCCI, LUIGI · 2009 to 2025
$4.0M
HISPANIC SECONDARY STROKE PREVENTION INITIATIVER01MD009164 · NIMHD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CARRASQUILLO, OLVEEN · 2014 to 2018
$1.9M
NIMHD NIH HHS R01 MD009164Wellcome Trust
6 · The paper itself

Abstract

Mastocytosis is a rare myeloid neoplasm characterized by uncontrolled expansion of mast cells, driven in >80% of affected individuals by acquisition of the KIT D816V mutation. To explore the hypothesis that inherited variation predisposes to mastocytosis, we performed a two-stage genome-wide association study, analyzing 1,035 individuals with KIT D816V positive disease and 17,960 healthy control individuals from five European populations. After quality control, we tested 592,007 SNPs at stage 1 and 75 SNPs at stage 2 for association by using logistic regression and performed a fixed effects meta-analysis to combine evidence across the two stages. From the meta-analysis, we identified three intergenic SNPs associated with mastocytosis that achieved genome-wide significance without heterogeneity between cohorts: rs4616402 (p

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyPolymorphism, Single NucleotideAmino Acid Transport System y+CCAAT-Enhancer-Binding ProteinsDNA, IntergenicFemaleHumansInterleukin-13IntronsMaleMastocytosisProto-Oncogene Proteins c-kitReceptors, Cytoplasmic and NuclearRepressor ProteinsRNA, Long NoncodingAmino Acid Transport System y+CCAAT-Enhancer-Binding ProteinsCEBPA protein, humanDNA, IntergenicIL13 protein, humanInterleukin-13KIT protein, humanProto-Oncogene Proteins c-kitReceptors, Cytoplasmic and NuclearRepressor ProteinsRNA, Long NoncodingSLC7A10 protein, humanTBL1XR1 protein, humanTelomeraseTERT protein, humanTPSAB1 protein, humanTryptasesCEBPAD816VKITmastocytosismyeloid cancerTBL1XR1TERT

Identifiers

PMID33421400
PMCPMC7895845
OpenAlexW3118794507

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.